Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell, Circulating Tumor”

Showing 20 of 0 results

Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Testing effectiveness (Phase 2)Looking for participantsNCT05582122
What this trial is testing

SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

Who this might be right for
Oropharynx Squamous Cell Carcinoma
UNICANCER 420
Not applicableUnknownNCT01847794
What this trial is testing

HER2 Positive CTC in Advanced Gastric Cancer

Who this might be right for
HER2 Positive Advanced Gastric Cancer
Peking University 50
Not applicableStudy completedNCT05247164
What this trial is testing

EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
IRCCS San Raffaele 23
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Post-approval studies (Phase 4)Study completedNCT02314871
What this trial is testing

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Who this might be right for
Colon CancerMinimal Residual Disease
The Institute of Molecular and Translational Medicine, Czech Republic 60
Not applicableStudy completedNCT04912687
What this trial is testing

Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid Tumor
Institut Bergonié 581
Not applicableUnknownNCT02055144
What this trial is testing

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 100
Not applicableUnknownNCT01930383
What this trial is testing

Circulating Tumor Cells for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularNeoplasm Circulating Cells
National Taiwan University Hospital 150
Not applicableStudy completedNCT02133222
What this trial is testing

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

Who this might be right for
Metastatic (Stage IV) Melanoma
Centre Hospitalier Universitaire de Nice 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05637567
What this trial is testing

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

Who this might be right for
Pancreatic Cancer Resectable
German Cancer Research Center 170
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Not applicableStudy completedNCT06777290
What this trial is testing

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Charles University, Czech Republic 14
Not applicableNot Yet RecruitingNCT05807646
What this trial is testing

Reduced Dissemination of Tumor Cells With Primary Ligation of the Inferior Mesenteric Vein in Rectal Cancer Patients.

Who this might be right for
Rectal Cancer
Sichuan Cancer Hospital and Research Institute 268
Not applicableStudy completedNCT04002570
What this trial is testing

Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients

Who this might be right for
Breast Cancer
Clinica Luganese Moncucco 13
Not applicableStudy completedNCT02032368
What this trial is testing

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Who this might be right for
Circulating Tumor Cell;Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 57
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Testing effectiveness (Phase 2)Looking for participantsNCT05628922
What this trial is testing

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Who this might be right for
Nasopharyngeal Cancer
Fudan University 198
Not applicableNot Yet RecruitingNCT07670442
What this trial is testing

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation